
Apollo Hospitals Enterprise Lt share price
NSE: APOLLOHOSP · Healthcare
₹8,771.00 +2.87%
Closing price data, updated 17 Nov 2026. 52-week range: -3.3% from high, +31.0% above low.
Price₹8,771.00
Market cap₹1,26,114 Cr
P/E56.2
P/B11.89
ROE21.9%
ROCE19.2%
Debt / equity0.90
Dividend yield0.00%
EPS₹155.94
Book value₹737.51
Operating margin11.7%
Dipscan score57 / 100
Share: WhatsAppX / TwitterTelegram
Apollo Hospitals Enterprise Lt shareholding pattern
As of Sep 2026: Promoters 28.02%, FIIs 43.18%, DIIs 22.07%, Government 0.23%, Public 4.46%, Others 2.03%.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Promoters | 28.02% | 28.02% | 28.02% | 28.02% | 28.02% | 29.34% |
| FIIs | 43.18% | 41.50% | 42.62% | 43.54% | 44.20% | 43.49% |
| DIIs | 22.07% | 23.72% | 22.76% | 21.51% | 21.12% | 21.34% |
| Government | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% | 0.23% |
| Public | 4.46% | 4.48% | 4.39% | 4.70% | 4.44% | 3.98% |
| Others | 2.03% | 2.05% | 1.98% | 2.01% | 1.99% | 1.62% |
| No. of Shareholders | 172,863 | 174,281 | 174,610 | 178,648 | 160,556 | 141,007 |
As filed by the company with the exchanges.
Returns
| 1 day | 1 week | 1 month | 3 months | 6 months | 1 year |
|---|---|---|---|---|---|
| +2.87% | +3.85% | +12.10% | +1.99% | +8.03% | +16.93% |
Growth
| Sales growth, 3 years | +14.8% |
| Sales growth, 5 years | – |
| Profit growth, 3 years | +33.3% |
| Profit growth, 5 years | – |
| Latest quarter sales vs last year | +23.0% |
| Latest quarter profit vs last year | – |
Strengths and weaknesses
Strengths
- Company has delivered good profit growth of 76.8% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 17.7%
Weaknesses
- Stock is trading at 11.9 times its book value
- Company might be capitalizing the interest cost
Peers in Healthcare
| Company | Price | Market cap | P/E | ROE | 1 year |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | ₹1,867.50 | ₹4,48,076 Cr | 40.9 | 14.7% | +8.8% |
| Divi's Laboratories Ltd. | ₹11,080.00 | ₹2,94,139 Cr | 87.5 | 16.2% | +69.4% |
| Torrent Pharmaceuticals Ltd. | ₹4,691.20 | ₹1,78,438 Cr | 84.0 | 27.1% | +22.6% |
| Laurus Labs Ltd. | ₹2,220.00 | ₹1,19,949 Cr | 89.5 | 18.2% | +125.2% |
| Zydus Lifesciences Ltd. | ₹1,192.00 | ₹1,18,902 Cr | 28.4 | 19.7% | +27.0% |
| Dr. Reddy's Laboratories Ltd. | ₹1,377.90 | ₹1,14,778 Cr | 41.0 | 12.1% | +13.7% |
| Cipla Ltd. | ₹1,394.50 | ₹1,12,658 Cr | 38.9 | 11.8% | -8.0% |
| Mankind Pharma Ltd. | ₹2,626.60 | ₹1,08,490 Cr | 48.4 | 12.5% | +18.3% |
Frequently asked questions
What is the share price of Apollo Hospitals Enterprise Lt?
Apollo Hospitals Enterprise Lt (APOLLOHOSP) last closed at ₹8,771.00 (+2.87% on the day).
What is the market cap of Apollo Hospitals Enterprise Lt?
About ₹1,26,114 Cr.
What is the P/E ratio of Apollo Hospitals Enterprise Lt?
The price-to-earnings ratio is 56.2, and return on equity is 21.9%.
Figures are calculated from company results and exchange prices and are for information only.